Skip to content

Retrospective real-world study of clinical application of fosfomycin tromethamine

Retrospective real-world study of clinical application of fosfomycin tromethamine

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015974
Enrollment
Unknown
Registered
2018-05-03
Start date
2018-05-03
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary system infection

Interventions

Case series:N/A

Sponsors

Beijing University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: 1) Extract prescription fosfomycin triammine triose; 2) The urinary tract infection requires two urine routine examinations before treatment and one week after treatment.

Exclusion criteria

Exclusion criteria: no

Design outcomes

Primary

MeasureTime frame
Clinical efficacy;

Countries

China

Contacts

Public ContactZheng Bo

Beijing University First Hospital

961678602@qq.com+86 13501210391

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026